<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>L-Asparaginase therapy for childhood <z:hpo ids='HP_0006721'>acute lymphoblastic leukemia</z:hpo> causes deficiencies of plasma hemostatic proteins, especially antithrombin, plasminogen, and fibrinogen </plain></SENT>
<SENT sid="1" pm="."><plain>Severe thromboses and <z:mp ids='MP_0001914'>hemorrhages</z:mp> occurred in 18 children receiving <z:chebi fb="0" ids="28445">vincristine</z:chebi>, <z:chebi fb="0" ids="8382">prednisone</z:chebi>, and asparaginase therapy for ALL </plain></SENT>
<SENT sid="2" pm="."><plain>Thirteen children had intracranial <z:mp ids='MP_0005048'>thrombosis</z:mp> or <z:mp ids='MP_0001914'>hemorrhage</z:mp>, four had extremity <z:mp ids='MP_0005048'>thrombosis</z:mp>, and one had both an <z:hpo ids='HP_0002170'>intracranial hemorrhage</z:hpo> and an extremity <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="3" pm="."><plain>These events occur characteristically in the third and fourth weeks of therapy during or just after a three-week course of L-asparaginase </plain></SENT>
<SENT sid="4" pm="."><plain>Symptoms of <z:hpo ids='HP_0002315'>headache</z:hpo>, obtundation, <z:hpo ids='HP_0001269'>hemiparesis</z:hpo>, and <z:hpo ids='HP_0001250'>seizure</z:hpo> were common for the intracranial events: local pain, swelling, and discoloration were common for the extremity thromboses </plain></SENT>
<SENT sid="5" pm="."><plain>These complications have been recognized in 1 to 2% of children undergoing induction therapy which includes asparaginase </plain></SENT>
</text></document>